Latest Cambridge Stories

HubSpot's Inbound Marketing Software Makes Social Media Personal Again CAMBRIDGE, Mass., May 7, 2013 /PRNewswire/ -- Today, HubSpot, Inc., an inbound marketing software company, introduced Social Inbox, a new application that tightly integrates social media monitoring and publishing with HubSpot's contact database, enabling marketers to make the most of highly segmented views of the social activity of their leads, customers, and biggest evangelists. The new integration reduces the...

CAMBRIDGE, Mass., May 7, 2013 /PRNewswire/ -- The Angiogenesis Foundation released a white paper that addresses the barriers faced by individuals in the Asia-Pacific region in seeking effective treatment for wet Age-Related Macular Degeneration (AMD), the second-leading cause of blindness in the world. The white paper, "Wet Age-Related Macular Degeneration in the Asia-Pacific: Critical Pathways Forward," is the result of the Asia-Pacific Wet Age-Related Macular Degeneration Expert...

--After Successful Pre-IND Meeting, Company On Track to Advance Lead Compound NPT002 into Clinical Trials for Alzheimer's Disease in 2014-- CAMBRIDGE, Mass., May 6, 2013 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round. Merieux Developpement led the financing with participation from all current Neurophage investors, including...

CAMBRIDGE, Mass., May 6, 2013 /PRNewswire-USNewswire/ -- WHAT: What will drivers have to pay for better fuel economy? The New England Motor Press Association and the Massachusetts Institute of Technology will host Hitting the Automotive Sweet Spot: Mass vs. Efficiency-the third in their annual series of panel discussions of leading-edge automotive issues. Chrysler is the presenting sponsor of the event. US federal regulations...

CAMBRIDGE, Mass., May 5, 2013 /PRNewswire/ -- The Angiogenesis Foundation released a new white paper, "Advocating for Improved Treatment and Outcomes for Wet Age-Related Macular Degeneration" (AMD). Wet AMD is the most common form of blindness in people 50 years or older in developed nations. The report is based on the Australian Wet Age-Related Macular Degeneration Coalition Expert Summit convened in Sydney, Australia last July by the Angiogenesis Foundation and Macular Degeneration...

- "Imagine if you had to call an electrician to turn on the lights in your house." CAMBRIDGE, Mass., May 1, 2013 /PRNewswire/ -- Many business professionals see their telephone platforms as being ... OK. Fine. Sufficient. Good enough. You don't often encounter companies describing their systems as "fantastic" or "awesome." And you never hear them say that it's easy to use or explain that it provides them with a competitive advantage. The unfortunate fact is that American...

CAMBRIDGE, Mass., May 2, 2013 /PRNewswire-USNewswire/ -- A new report from the American Academy of Arts & Sciences offers recommendations for academia, government agencies, and the private sector to help maintain America's leadership in science, technology, and medicine. The report, ARISE II: Unleashing America's Research & Innovation Enterprise, highlights the need for greater synergy between government, university, and industry research. It advocates for greater...

CEO Rob May to Speak to Event Attendees on the Importance of Taking Control of Business Data in the Cloud CAMBRIDGE, Mass., May 2, 2013 /PRNewswire/ -- Backupify, the leading provider of cloud-to-cloud backup and recovery solutions for Software as a Service (SaaS) applications, will be participating in several upcoming CIO events to share best practices on protecting digital assets in the cloud. According to a recent Aberdeen Group report, "SaaS Data Loss: The Problem You Didn't Know...

CAMBRIDGE, Mass., May 2, 2013 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it has added two members to its board of directors: Robert Sepucha Jr. and Michael M. Smith. The Institute's board grows to include 14 members with deep ties to the ALS community, academic research, philanthropy and pharmaceutical development. (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO) Robert Sepucha Jr. is senior vice president, policy...

CAMBRIDGE, Mass., April 30, 2013 /PRNewswire/ -- Catabasis Pharmaceuticals Inc., announced that the United States Patent and Trademark Office has issued patents that cover CAT-1000 and CAT-2000 series compounds. One patent (U.S. Patent No. 8,173,831) covers the CAT-1000 series' conjugation of salicylate and an omega-3 fatty acid using Catabasis' SMART Linker technology; the compounds in this series are intended to treat diseases involving chronic inflammation such as inflammatory...